JPH203

CAS No. 1037592-40-7

JPH203( KYT-0353 | KYT0353 | KYT 0353 | JPH-203 )

Catalog No. M10188 CAS No. 1037592-40-7

JPH203 (KYT-0353)?is a potent, selective L-type amino acid transporter 1 (LAT1, SLC7A5) inhibitor with IC50 of 60 nM (leucine uptake inhibition).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 53 In Stock
5MG 76 In Stock
10MG 109 In Stock
25MG 182 In Stock
50MG 327 In Stock
100MG 420 In Stock
200MG 620 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    JPH203
  • Note
    Research use only, not for human use.
  • Brief Description
    JPH203 (KYT-0353)?is a potent, selective L-type amino acid transporter 1 (LAT1, SLC7A5) inhibitor with IC50 of 60 nM (leucine uptake inhibition).
  • Description
    JPH203 (KYT-0353)?is a potent, selective L-type amino acid transporter 1 (LAT1, SLC7A5) inhibitor with IC50 of 60 nM (leucine uptake inhibition), but not LAT2; inhibits cell growth in HT-29 cells with IC50 of 4.1 uM, also inhibits (14)C-leucine uptake in mouse renal proximal tubule cells expressing LAT1 and inhibits cell growth with IC50 of 0.14 and 16.4 uM, respectively; significant inhibits HT-29 tumor growth in vivo.Solid Tumors Phase 1 Clinical.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    KYT-0353 | KYT0353 | KYT 0353 | JPH-203
  • Pathway
    Apoptosis
  • Target
    Apoptosis
  • Recptor
    Apoptosis
  • Research Area
    Cancer
  • Indication
    Solid Tumors

Chemical Information

  • CAS Number
    1037592-40-7
  • Formula Weight
    472.32066
  • Molecular Formula
    C23H19Cl2N3O4
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    C1=CC=C(C=C1)C2=NC3=CC(=CC(=C3O2)COC4=C(C=C(C=C4Cl)CC(C(=O)O)N)Cl)N
  • Chemical Name
    L-Tyrosine, O-[(5-amino-2-phenyl-7-benzoxazolyl)methyl]-3,5-dichloro-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Oda K, et al. Cancer Sci. 2010 Jan;101(1):173-9. 2. Yun DW, et al. J Pharmacol Sci. 2014;124(2):208-17. 3. Wempe MF, et al. Drug Metab Pharmacokinet. 2012;27(1):155-61. 4. Rosilio C, et al. Leukemia. 2015 Jun;29(6):1253-66.
molnova catalog
related products
  • Pamrevlumab

    Pamrevlumab (FG-3019) is a human antibody with affinity for connective tissue growth factor (CTGF) and is involved in anti-CTGF therapy for the treatment of idiopathic pulmonary fibrosis (IPF).

  • AGN 192870

    AGN 192870 is a potent retinoic acid receptor (RAR) antagonist.AGN 192870 can be used to study cell growth arrest, differentiation and apoptosis.

  • HNPMI

    HNPMI is an EGFR inhibitor that induces G0/G1 phase arrest of CRC cells in colorectal cancer, regulates enzymes associated with apoptosis, and can promote apoptosis, and can be used for the study of colorectal cancer.